Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01601067 · ClinicalTrials.gov registry record · Phase 2
Integrated Alcohol Disorder and PTSD Treatment
A Phase 2 study of PTSD and Alcoholism, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 168
- Enrollment target
- 1
- Study location
NCT01601067 is a Phase 2 study of PTSD and Alcoholism that has completed, run by VA Office of Research and Development. The registered enrollment target is 168 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01601067, a Phase 2 study of PTSD and Alcoholism, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
Comorbidity of alcohol use disorder (AD) and posttraumatic stress disorder (PTSD) is common. Currently available treatments often do not lead to sustained recovery from these disorders, possibly because they typically do not include exposure therapy which is considered best practice treatments for PTSD. This study compares exposure-based integrated treatment to integrated coping skills psychotherapy (a well disseminated practice) for comorbid AD and PTSD with the hypothesis that exposure therapy will allow those with PTSD to better sustain PTSD symptom reduction and reduction in alcohol use. The aim of this grant is to change common treatment practices for comorbid AD and PTSD by increasing the availability of evidence-based PTSD treatment for those with AD.
Conditions Studied
Interventions
- BEHAVIORAL Seeking Safety
- BEHAVIORAL Integrated Prolonged Exposure Therapy
Study Locations (1)
California
- VA San Diego Healthcare System, San Diego, CA - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2013-01-21 |
| Est. Completion | 2018-03-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01601067
The ClinicalTrials.gov registry entry for NCT01601067 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (44% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Seeking Safety is the first listed.
NCT01601067 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01601067 about?
NCT01601067 is a clinical study titled "Integrated Alcohol Disorder and PTSD Treatment". Comorbidity of alcohol use disorder (AD) and posttraumatic stress disorder (PTSD) is common. Currently available treatments often do not lead to sustained recovery from these disorders, possibly because they typically do not include exposure therapy which is considered best practice treatments for P...
What is the current status of trial NCT01601067?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2013-01-21. Estimated completion is 2018-03-30.
What conditions does trial NCT01601067 study?
This clinical trial studies the following conditions: PTSD, Alcoholism.
What interventions are being tested in trial NCT01601067?
The interventions under investigation include: Seeking Safety (BEHAVIORAL), Integrated Prolonged Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01601067?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01601067 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
RECRUITING · Phase 2
-
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder
RECRUITING · Phase 2
-
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
RECRUITING · Phase 2
-
Induction of Dreaming With EEG and Anesthesia for Post-traumatic Stress Disorder
RECRUITING · Phase 2
-
Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
RECRUITING · Phase 2
-
Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.